R. Gray

发表

Heart rate variability alterations in late life depression: A meta-analysis.

Chandan Karmakar, L. Brown, C. Karmakar, 2018, Journal of affective disorders.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Managing Critically Ill Patients with Esmolol* An UltraShort-Acting13-Adrenergic Blocker

R. Gray, 2015 .

Efficacy of Esmolol in the Treatment and Transfer of Patients with Supraventricular Tachyarrhythmias to Alternate Oral Antiarrhythmic Agents

T. Hua, F. Mcgrew, R. Gray, 1988, Journal of clinical pharmacology.

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.

Eric E. Smith, Dawn R. Anderson, P. Dorman, 2021, Lancet.

Myocardial Infarction Referral) Hospital Perspective Patients. The Non-Percutaneous Coronary Intervention-Capable (ST-Elevation Development of Systems of Care for ST-Elevation Myocardial Infarction

L. Hiratzka, B. Brodie, R. Gray, 2007 .

Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

R. Peto, S. Yusuf, D. Ramsdale, 1983, Circulation.

Early Intravenous Atenolol in Suspected Acute Myocardial Infarction: Final Report of a Randomised Clinical Trial

R. Peto, S. Yusuf, D. Ramsdale, 1984 .

INFARCTION: FINAL REPORT OF A RANDOMISED CLINICAL TRIAL

R. Peto, S. Yusuf, S. Parish, 1984 .

Safer non-cardiac surgery for patients with coronary artery disease

R. Gray, J. Sonksen, Peter Hutton Hickman, 1998, BMJ.

Management of the Femoral Artery After Transluminal Repair of Abdominal Aortic Aneurysms

J. Laird, R. Gray, D. Kohlman-Trigoboff, 1999 .

Reduction in Infarct Size, Arrhythmias, Chest Pain and Morbidity by Early Intravenous β-Blockade in Suspected Acute Myocardial Infarction

R. Peto, S. Yusuf, D. Ramsdale, 2012, Drugs.

Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: The Non–Percutaneous Coronary Intervention–Capable (ST-Elevation Myocardial Infarction Referral) Hospital Perspective

L. Hiratzka, B. Brodie, R. Gray, 2007, Circulation.

Life changes and urinary norepinephrine in myocardial infarction.

D. Sleet, R. Gray, J. C. Carson, 1983, Journal of human stress.

Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure. Relationship to arterial PCO2.

P. Hanly, R. Gray, R. Gray, 1993, Chest.

A national survey of GP and nurse attitudes and beliefs towards depression after myocardial infarction.

R. Gray, J. Ramjeet, J. Haws, 2011, Journal of clinical nursing.

REDUCTION IN INFARCT SIZE, MORBIDITY AND SHORT-TERM MORTALITY BY EARLY INTRAVENOUS BETABLOCKADE

R. Peto, S. Yusuf, D. Ramsdale, 1983 .

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.

R. Gray, R. Pathmanathan, P. Stafford, 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Nicardipine versus placebo for the treatment of postoperative hypertension.

J. S. Goldberg, J. Seltzer, N. Halpern, 1988, American heart journal.

MATTERS ARISING

R. Gray, 1991 .